News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Glucose Control Okay With Novel Thrice-Weekly Insulin, Mount Sinai Hospital Study


3/10/2011 6:26:20 AM

MedPageToday -- A novel insulin that releases over several days appears as effective as once-daily standard insulin in type 2 diabetes, an open-label trial found. Glycosylated hemoglobin levels reached a similar 7.2% to 7.5% over 16 weeks whether patients got the novel insulin degludec three times a week or once daily, or standard insulin glargine (Lantus) once daily, Bernard Zinman, MD, of Mount Sinai Hospital at the University of Toronto, and colleagues reported online in The Lancet.

Read at MedPageToday
Read at CTV.ca
Read at Politics Live
Read at WebMD


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES